|
Market Closed -
Nasdaq
16:00:00 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 216.27 USD | +1.22% |
|
+1.66% | +18.41% |
| 08-12 | UBS Adjusts Price Target on Axsome Therapeutics to $280 From $259, Keeps Buy Rating | MT |
| 08-12 | Mizuho Adjusts PT on Axsome Therapeutics to $316 From $306, Keeps Outperform Rating | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Developing and Delivering novel therapies for the management of CNS disorders | - | 50.04M | 271M | 386M | 638M | |||||
Total Assets | 87.79M | 331M | 588M | 568M | 690M | |||||
Interest Expense | -5.7M | -7.33M | -6.45M | -6.57M | -15.93M | |||||
Income Tax Expense | - | - | 960K | 85K | -530K | |||||
CAPEX | -308K | -702K | -582K | -270K | -480K | |||||
EBT | -130M | -187M | -238M | -287M | -184M | |||||
D&A | 1.16M | 5.56M | 459K | 7.96M | 9.06M | |||||
Operating Income | -125M | -180M | -232M | -281M | -167M | |||||
Net Income | -130M | -187M | -239M | -287M | -183M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | - | 50.04M | 197M | 378M | 629M | |||||
Total Assets | 87.79M | 331M | - | - | - | |||||
Interest Expense | -5.7M | -7.33M | - | - | - | |||||
D&A | 1.16M | 5.56M | - | - | - | |||||
CAPEX | -308K | -702K | - | - | - | |||||
Net Income | -130M | -187M | - | - | - | |||||
EBT | -130M | -187M | - | - | - | |||||
Operating Income | -125M | -180M | - | - | - | |||||
Outside of The United States | - | - | 73.38M | 7.53M | 9.88M |
- Stock Market
- Stocks
- AXSM Stock
- Financials Axsome Therapeutics, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
